Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KLRA

Kailera Therapeutics Inc

May 29 • 04:00PM ET

22.94

0.00 0.00 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: VKTX NAMS MDGL BMRN KRYS RYTM INCY AXSM KROS NBIX

| Held by: VTI VB VBR VBK OZEM VXF VTWO VTWG VTWV TNXT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	31.03%	Shs Outstand	129.57M	Perf Week	8.82%
Market Cap	2.97B	Forward P/E	-	EPS next Y	-3.84	Insider Trans	103.23%	Shs Float	89.36M	Perf Month	-7.35%
Enterprise Value	3.46B	PEG	-	EPS next Q	-0.77	Inst Own	12.18%	Short Float	2.97%	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-97.05%	Inst Trans	28.62%	Short Ratio	2.82	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-6.58%	ROA	-	Short Interest	2.66M	Perf YTD	-11.77%
Book/sh	-3.33	P/C	5.73	EPS next 5Y	-23.04%	ROE	-	52W High	28.23 -18.73%	Perf Year	-
Cash/sh	4.01	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	19.01 20.67%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.61% 7.43%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	1.75	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.67	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	50.24	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.67	EPS Q/Q	-	SMA20	3.60%	Beta	-	Target Price	42.75
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	0.08%	Rel Volume	0.59	Prev Close	22.94
Employees	145	LT Debt/Eq	-	Earnings	May 26 AMC	SMA200	0.08%	Avg Volume	941.27K	Price	22.94
IPO	Apr 17, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	-470867.74% -	Trades		Volume	555,944	Change	0.00%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)